Given the suppressive phagocytic function of LAMs and LAM-induced immune dysfunction in response to iron overload, we investigated whether in vivo LAM depletion alters the effects of iron overload on AML progression (Figure 7A). The gene discussed is LAMB2; the disease is acute myeloid leukemia.